IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 149 filers reported holding IMPAX LABORATORIES INC in Q2 2013. The put-call ratio across all filers is 2.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $2,203,000 | +16.8% | 113,249 | 0.0% | 0.00% | +100.0% |
| Q4 2017 | $1,886,000 | -54.4% | 113,249 | -44.4% | 0.00% | -66.7% |
| Q3 2017 | $4,137,000 | +126.9% | 203,769 | +79.9% | 0.00% | +200.0% |
| Q2 2017 | $1,823,000 | +14.6% | 113,249 | -9.9% | 0.00% | 0.0% |
| Q1 2017 | $1,591,000 | -4.5% | 125,749 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $1,666,000 | -67.7% | 125,749 | -42.2% | 0.00% | -75.0% |
| Q3 2016 | $5,155,000 | +42.2% | 217,529 | +73.0% | 0.00% | +33.3% |
| Q2 2016 | $3,624,000 | -6.2% | 125,749 | +4.2% | 0.00% | 0.0% |
| Q1 2016 | $3,863,000 | -25.1% | 120,649 | 0.0% | 0.00% | -25.0% |
| Q4 2015 | $5,159,000 | +20.7% | 120,649 | -0.6% | 0.00% | 0.0% |
| Q3 2015 | $4,273,000 | -29.8% | 121,349 | -8.5% | 0.00% | -20.0% |
| Q2 2015 | $6,091,000 | +1.2% | 132,649 | +3.4% | 0.01% | 0.0% |
| Q1 2015 | $6,016,000 | +48.3% | 128,349 | +0.2% | 0.01% | +66.7% |
| Q4 2014 | $4,057,000 | +48.3% | 128,049 | +11.0% | 0.00% | +50.0% |
| Q3 2014 | $2,735,000 | -30.1% | 115,349 | -11.6% | 0.00% | -33.3% |
| Q2 2014 | $3,915,000 | +10.0% | 130,549 | -3.1% | 0.00% | 0.0% |
| Q1 2014 | $3,560,000 | +5.1% | 134,747 | +0.0% | 0.00% | 0.0% |
| Q4 2013 | $3,386,000 | +4.4% | 134,690 | -14.9% | 0.00% | 0.0% |
| Q3 2013 | $3,244,000 | +2.8% | 158,184 | -0.0% | 0.00% | 0.0% |
| Q2 2013 | $3,156,000 | – | 158,185 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aravt Global | 3,071,878 | $131,354,000 | 13.28% |
| BANBURY PARTNERS LLC | 480,179 | $20,532,000 | 8.33% |
| Krensavage Asset Management, LLC | 585,170 | $25,022,000 | 7.98% |
| Hound Partners | 6,980,266 | $298,476,000 | 6.77% |
| BLUE JAY CAPITAL MANAGEMENT, LLC | 295,000 | $12,614,000 | 4.25% |
| GIOVINE CAPITAL GROUP LLC | 59,805 | $2,557,000 | 3.72% |
| ATERNALIS CAPITAL LLC | 130,000 | $5,559,000 | 3.65% |
| Asymmetry Capital Management, L.P. | 51,430 | $2,199,000 | 3.32% |
| Orbimed Advisors | 6,664,100 | $284,957,000 | 2.58% |
| Pennant Capital Management, LLC | 2,321,581 | $99,271,000 | 2.52% |